489 related articles for article (PubMed ID: 10160112)
1. Pharmacoeconomics and formulary decision making.
Sanchez LA
Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
[TBL] [Abstract][Full Text] [Related]
2. Application of pharmacoeconomics to formulary decision making in managed care organizations.
Suh DC; Okpara IR; Agnese WB; Toscani M
Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
[TBL] [Abstract][Full Text] [Related]
3. The use of pharmacoeconomic data in formulary selection.
Hatoum HT; Freeman RA
Top Hosp Pharm Manage; 1994 Jan; 13(4):47-53. PubMed ID: 10130683
[TBL] [Abstract][Full Text] [Related]
4. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
5. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis and the formulary decision-making process.
Wang Z; Salmon JW; Walton SM
J Manag Care Pharm; 2004; 10(1):48-59. PubMed ID: 14720105
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic analysis in formulary decisions: an international perspective.
Johnson JA; Bootman JL
Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer TL
Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomics: a managed care perspective.
Clouse JC
Top Hosp Pharm Manage; 1994 Jan; 13(4):54-9. PubMed ID: 10130684
[TBL] [Abstract][Full Text] [Related]
10. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
11. A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment.
Veenstra DL; Ramsey SD; Sullivan SD
Pharmacoeconomics; 2002; 20 Suppl 1():21-30. PubMed ID: 12036381
[TBL] [Abstract][Full Text] [Related]
12. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
Mullins CD; Wang J
Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
[TBL] [Abstract][Full Text] [Related]
13. The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspective.
Thomas N
Pharmacoeconomics; 1996; 9 Suppl 1():9-15. PubMed ID: 10160115
[TBL] [Abstract][Full Text] [Related]
14. The use of pharmacoeconomic data in managed care: closing the credibility gap.
Lewis BE
Manag Care Interface; 1997 Nov; 10(11):99-103. PubMed ID: 10174761
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomics and the formulary decision-making process.
Bakst A
Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
[TBL] [Abstract][Full Text] [Related]
16. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
Bukstein DA
Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
[TBL] [Abstract][Full Text] [Related]
17. Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience.
Watkins JB; Minshall ME; Sullivan SD
J Manag Care Pharm; 2006; 12(9):726-35. PubMed ID: 17249905
[TBL] [Abstract][Full Text] [Related]
18. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature.
Sanchez LA
Am J Health Syst Pharm; 1999 Aug; 56(16):1630-8; quiz 1638-40. PubMed ID: 10459385
[TBL] [Abstract][Full Text] [Related]
19. Showing outcomes and proving value brings success.
Fullerton DS; Atherly D; Sullivan SD
Manag Care Interface; 2001 Jun; 14(6):63-5, 71. PubMed ID: 11432153
[TBL] [Abstract][Full Text] [Related]
20. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
